Adenylate cyclase 1 knockdown attenuates pirarubicin‐induced cardiotoxicity
This study aimed to investigate the effects and possible mechanisms of adenylate cyclase 1 (ADCY1) on pirarubicin-induced cardiomyocyte injury. HL-1 cells were treated with pirarubicin (THP) to induce intracellular toxicity, and the extent of damage to mouse cardiomyocytes was assessed using CCK-8, Edu, flow cytometry, ROS, ELISA, RT-qPCR and western blotting. THP treatment reduced the viability of HL-1 cells, inhibited proliferation, induced apoptosis and triggered oxidative stress. In addition, the RT-qPCR results revealed that ADCY1 expression was significantly elevated in HL-1 cells, and molecular docking showed a direct interaction between ADCY1 and THP. Western blotting showed that ADCY1, phospho-protein kinase A and GRIN2D expression were also significantly elevated. Knockdown of ADCY1 attenuated THP-induced cardiotoxicity, possibly by regulating the ADCY1/PKA/GRIN2D pathway.
Authors
- Dexian Wei
- Jiahua Ji
- Liqun Ren (ORCID: https://orcid.org/0000-0002-9390-2091)
- Wenqing Zhang (ORCID: https://orcid.org/0000-0002-5119-1658)
- Peng Huang (ORCID: https://orcid.org/0000-0001-8556-5606)
- HongYuan Cheng
- Zhiyun Shu (ORCID: https://orcid.org/0009-0005-0285-2818)
Institutions
- Jilin University (CN)
Publication Details
- Journal
- Clinical and Experimental Pharmacology and Physiology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1111/1440-1681.13920
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China